We are seeking a highly motivated individual who will bring their knowledge and laboratory skills to the study of cancer… Click here to view original post
Absci’s integrated drug creation platform increases the speed and efficiency of the drug discovery process. Click here to view original post
Measure 110 has come under fire in recent weeks as the drug addiction crisis has worsened. Click here to view original post
While funding slid since 2020, it remained well above $400 million in 2022, supporting important research at Oregon’s public universities, health-related nonprofits and biotech startups. Click here to view original post
The group of 250 advanced practice providers has concerns about Legacy’s “emphasis on revenue over patient safety and staff well-being.” Click here to view original post
Joe Arron and Mark Eisner worked together for about a decade at Genentech, with broad remits but a shared passion for interstitial lung disease. They’d go their separate ways a few years ago — Arron […]
SOUTH SAN FRANCISCO, Calif. & SEATTLE–(BUSINESS WIRE)–Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the appointments of Joseph R. Arron, M.D., Ph.D., […]
Associate Director/Director Bioassays will report to the SVP of Drug Creation and lead a scientific team to advance Absci’s internal… Click here to view original post
WellRithms serves self-insured companies by reviewing medical claims for billing errors, fraud, abuse and other things that can inflate bills at the expense of employers. Click here to view original post
Dr. Frank Lau came up with a way to find a better therapy match before it’s tried out on the patient. Click here to view original post
Copyright © 2023 Biotech Networks, LLC
